Amphastar Pharmaceuticals, Inc. (AMPH) Operating cash flow 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$156.1MFY2025 · since FY2016: $38.6M → $156.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $156.1M | -26.8% |
| FY2024 | $213.4M | +16.3% |
| FY2023 | $183.5M | +105.8% |
| FY2022 | $89.2M | -9.0% |
| FY2021 | $98.0M | +71.1% |
| FY2020 | $57.3M | +37.1% |
| FY2019 | $41.8M | +9.4% |
| FY2018 | $38.2M | -2.6% |
| FY2017 | $39.2M | +1.7% |
| FY2016 | $38.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice